HomeCLN • WSE
add
Celon Pharma SA
Previous close
zł 20.20
Day range
zł 19.96 - zł 20.45
Year range
zł 19.60 - zł 28.65
Market cap
1.08B PLN
Avg Volume
12.02K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 71.13M | 39.34% |
Operating expense | 46.24M | 297.41% |
Net income | 3.66M | -93.59% |
Net profit margin | 5.15 | -95.40% |
Earnings per share | — | — |
EBITDA | 16.34M | -76.60% |
Effective tax rate | 232.29% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.03M | -79.64% |
Total assets | 471.34M | -23.87% |
Total liabilities | 82.14M | -20.18% |
Total equity | 389.19M | — |
Shares outstanding | 53.86M | — |
Price to book | 2.79 | — |
Return on assets | 4.23% | — |
Return on capital | 4.99% | — |
Cash Flow
Net change in cash
| (PLN) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 3.66M | -93.59% |
Cash from operations | -4.88M | 66.89% |
Cash from investing | 10.02M | 347.12% |
Cash from financing | -6.93M | -389.68% |
Net change in cash | -1.78M | 91.17% |
Free cash flow | 4.87M | -85.31% |
About
Founded
2002
Website
Employees
566
